Genexine Inc (Genexine), formerly Genexine Co Ltd, is a clinical-stage biotechnology company that develops and commercializes immunotherapeutics and next-generation novel long-acting biologics. The company also develops therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs. Its pipeline products include GX-H9, GX-G8, rhIL-7-hyFc, GX-G3, GX-G6, HPV DNA Vaccine and IL-7-hyFc. Genexine develops products for various therapeutic areas such as orphans, cancers and also immune disorders. The company uses hybrid Fc technology platform for the discovery of a wide range of differentiated agonistic protein therapeutics. It partners with other pharmaceutical companies for its research and development activities. The company has operations in the US and South Korea. Genexine is headquartered in Seongnam, South Korea
Genexine Inc premium industry data and analytics
Products and Services
Products |
---|
GX-I7: |
Cancers |
GX-188E: |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Genexine Inc | Dong-A Socio Holdings Co Ltd | CrystalGenomics Inc | Mezzion Pharma Co Ltd | Naturalendo Tech Co Ltd |
---|---|---|---|---|---|
Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
City | Seoul | Seoul | Seongnam | Seoul | Seongnam |
No. of Employees | 161 | 273 | 64 | 24 | 62 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Young-Jin Kim | Chairman | Executive Board | - | - |
Neil K. Warma | Director; Chief Executive Officer; President | Executive Board | - | - |
Sung June Hong | Chief Financial Officer; Executive Vice President; Director | Executive Board | - | - |
Jungwon Woo | Director; President | Executive Board | - | - |
Hyun-Jin Park | Executive Vice President - Corporate Development | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward